Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An algorithm for generating biophysically realistic three-dimensional arteriolar networks applied to rat skeletal muscle.

Physiological reports·2025
Same author

Sterile Inflammation in Mouse Lung Driven by Lipid Mediator Pathways Following MWCNT Exposure.

Chemical research in toxicology·2025
Same author

Assessing Sex Differences in Metabolic Disease on Vasculopathy Using the Vascular Health Index.

Journal of vascular research·2025
Same author

Pulmonary inflammatory and fibrogenic responses in rats following intratracheal instillation of dusts from natural and engineered stones.

Journal of toxicology and environmental health. Part A·2025
Same author

ChatGPT-polished writing boosts the risk of human-authored manuscripts being miscredited as AI-generated.

JAAD international·2025
Same author

Potassium as an electro-metabolic signal for local coronary vasodilation.

Basic research in cardiology·2025
Same journal

Intersections as Hot Spots: Assessing the Contribution of Localized Nontailpipe Emissions and Noise on the Association Between Traffic and Children's Lung Function.

Research report (Health Effects Institute)·2026
Same journal

Accounting for the Health Benefits of Air Pollution Regulations in China, 2008-2019.

Research report (Health Effects Institute)·2026
Same journal

Monitoring and Modeling Population Exposures to Air Pollutants from Oil and Gas Development: Part 1. Predictive, Source-Oriented Modeling and Measurements to Evaluate Community Exposures to Air Pollutants and Noise from Unconventional Oil and Gas Development.

Research report (Health Effects Institute)·2026
Same journal

Early-Life Air Pollution Exposure Is Associated with the Infant Gut Microbiome and Fecal Metabolome in the First Two Years of Life.

Research report (Health Effects Institute)·2026
Same journal

Ambient Air Pollution and COVID-19 in California.

Research report (Health Effects Institute)·2026
Same journal

Traffic-Related Air Pollution and Birth Weight: The Roles of Noise, Placental Function, Green Space, Physical Activity, and Socioeconomic Status (FRONTIER).

Research report (Health Effects Institute)·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

Pulmonary particulate matter and systemic microvascular dysfunction.

Timothy R Nurkiewicz1, Dale W Porter, Ann F Hubbs

  • 1The Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia 26506-9105, USA.

Research Report (Health Effects Institute)
|February 15, 2012
PubMed
Summary
This summary is machine-generated.

Inhaled fine and nano-sized particulate matter (PM) impairs microvascular function by reducing nitric oxide (NO) availability, increasing oxidative stress, and involving neutrophils and neural mechanisms.

More Related Videos

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
08:21

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

Related Experiment Videos

Last Updated: May 25, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
08:21

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

Area of Science:

  • Environmental Health
  • Cardiovascular Physiology
  • Toxicology

Background:

  • Epidemiological studies link pulmonary particulate matter (PM) exposure to cardiovascular disease, but underlying mechanisms remain unclear.
  • Systemic microcirculation, crucial for peripheral resistance and disease origin, has not been studied in relation to PM exposure.
  • Ultrafine PM (nanoparticles) may be more toxic due to higher surface area per mass.

Purpose of the Study:

  • To determine if PM particle size affects microvascular dysfunction severity.
  • To characterize alterations in microvascular nitric oxide (NO) production post-PM exposure.
  • To investigate the roles of oxidative stress, inflammation, neutrophils, and neural mechanisms in PM-induced microvascular dysfunction.

Main Methods:

  • Rats were exposed to fine or nano-titanium dioxide (TiO2) PM via inhalation.
  • Microvascular function, NO production, and oxidative stress were assessed using in vivo microscopy and biochemical analyses.
  • Interventions included antioxidant, myeloperoxidase (MPO), and NADPH oxidase inhibitors, neutrophil depletion, and neural blockade.

Main Results:

  • PM exposure decreased endothelium-dependent arteriolar dilation, with nano-PM causing greater dysfunction.
  • Microvascular NO production decreased, while oxidative stress increased in both fine and nano-PM groups.
  • Antioxidants, MPO/NADPH oxidase inhibitors, neutrophil depletion, and neural blockade partially restored arteriolar function.

Conclusions:

  • PM particle size dictates the severity of systemic microvascular dysfunction.
  • Dysfunction is characterized by reduced NO bioavailability, linked to oxidative stress, inflammation, and potentially neutrophils and neural pathways.
  • These findings support inflammatory and/or neurogenic mechanisms underlying PM-associated vascular effects.